COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis.

Norimatsu, Yuta; Yoshizaki, Ayumi; Fukasawa, Takemichi; Ebata, Satoshi; Oba, Koji; Sato, Shinichi

Norimatsu, Yuta; Yoshizaki, Ayumi; Fukasawa, Takemichi; Ebata, Satoshi; Oba, Koji; Sato, Shinichi.

Norimatsu Y; Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Yoshizaki A; Department of Dermatology, The University of Tokyo Graduate School of Medicine, and Systemic Sclerosis Center, The University of Tokyo Hospital, Tokyo, Japan. ayuyoshi@me.com.
Fukasawa T; Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Ebata S; Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Oba K; Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Japan.
Sato S; Department of Dermatology, The University of Tokyo Graduate School of Medicine, and Systemic Sclerosis Center, The University of Tokyo Hospital, Tokyo, Japan.

Clin Exp Rheumatol ; 39 Suppl 131(4): 160, 2021.

Article in English | MEDLINE | ID: covidwho-924864

Subject(s)

COVID-19; Collagen Diseases; Scleroderma, Systemic; Telemedicine; Humans; Pandemics; SARS-CoV-2; Scleroderma, Systemic/diagnosis; Scleroderma, Systemic/epidemiology; Scleroderma, Systemic/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Scleroderma, Systemic / Telemedicine / Collagen Diseases / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2021 Document Type: Article Affiliation country: Japan

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google